Phase 2 Crohn's Disease and Colitis Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People who have been diagnosed with moderately to severely active ulcerative colitis (a type of inflammatory bowel disease affecting the large intestine)
- People who are currently taking certain approved medications for ulcerative colitis at the recommended treatment dose
Who may not be able to join:
- People whose ulcerative colitis is classified as severe and affecting a large portion of the colon
- People who have been diagnosed with Crohn's disease, indeterminate colitis, or who have or have had a type of tunnel-like tract (fistula) in the gut that is associated with Crohn's disease
- People who have been diagnosed with microscopic colitis, ischemic colitis (reduced blood flow to the colon), or colitis caused by an infection
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Pfizer CT.gov Call Center, Pfizer
Phone: 1-800-718-1021
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Number and percent of enrolled participants with clinical remission based on Modified Mayo Score (MMS) at Week 52
Can't join this trial?
Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.